Dullins, France

Lapierre Yves


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lapierre Yves: Innovator in Diagnostic Methods

Introduction

Lapierre Yves is a notable inventor based in Dullins, France. He has made significant contributions to the field of diagnostics, particularly in the detection of antigens and antibodies. With a total of 3 patents to his name, Yves continues to push the boundaries of innovation in medical technology.

Latest Patents

Yves's latest patents include a method and test kit for detecting antigens and/or antibodies. This innovative approach involves preparing a suspension of inert particles in an aqueous solution, to which an antibody or antigen is added. After centrifuging, the results can be easily interpreted based on a simple pattern, indicating positive, weakly positive, or negative reactions. Another patent focuses on methods and cards for detecting antigens or antibodies in fluid samples. In this method, a fluid sample is added to a microreaction vessel containing a slurry suspension of inert particles and a binding partner. The binding partners form an optically detectable complex, allowing for the determination of the presence of the antibody.

Career Highlights

Yves works at Stiftung für Diagnostische Forschung, where he applies his expertise in diagnostic research. His work has been instrumental in developing new methods that enhance the accuracy and efficiency of diagnostic tests.

Collaborations

Yves collaborates with esteemed colleagues, including Susanne Greber-Widmer and Dieter Josef. Their combined efforts contribute to advancing the field of diagnostics and improving patient outcomes.

Conclusion

Lapierre Yves is a pioneering inventor whose work in diagnostic methods has the potential to revolutionize the way antigens and antibodies are detected. His innovative patents and collaborations highlight his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…